Evidence map›Paper›PMID 37747938›Full record

ArticlePLoS pathogens2023

Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake.

Rodger de Miranda, Bonnie J Cuthbert, Thaís Klevorn, Alex Chao, Jessica Mendoza, Mark Arbing, Paul J Sieminski, Kadamba Papavinasasundaram, Sumer Abdul-Hafiz, Sum Chan and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Structure, assembly, and mechanism of the MmpL family of transporters.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Microorganisms · 2025
    Article
  8. Siderophores as tools and treatments.npj antimicrobials and resistance · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Rodger de MirandaDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Bonnie J CuthbertDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Thaís KlevornDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
Alex ChaoDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Jessica MendozaDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Mark ArbingUCLA-DOE Institute, UCLA, Los Angeles, Calofornia, United States of America.
Paul J SieminskiDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Kadamba PapavinasasundaramDepartment of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Sumer Abdul-HafizDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Sum ChanDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
Christopher M SassettiDepartment of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Sabine EhrtDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
Celia W GouldingDepartment of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
Cornell University · USUniversity of California, Irvine · USUniversity of Massachusetts Chan Medical School · US

Funding

Vulnerabilities in Mycobacterial Cell-Wall BiogenesisP01AI095208 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SACCHETTINI, JAMES C · 2012 to 2022
$19.8M
T32 for Training in Microbiology & Infectious DiseasesT32AI141346 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Celia Goulding, Melissa Bruckner Lodoen · 2019 to 2026
$1.0M
NIAID NIH HHS P01 AI095208NIAID NIH HHS T32 AI141346
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, poses a great threat to human health. With the emergence of drug resistant Mtb strains, new therapeutics are desperately needed. As iron is critical to the growth and survival of Mtb, mechanisms through which Mtb acquires host iron represent attractive therapeutic targets. Mtb scavenges host iron via Mtb siderophore-dependent and heme iron uptake pathways. While multiple studies describe the import of heme and ferric-siderophores and the export of apo-siderophores across the inner membrane, little is known about their transport across the periplasm and cell-wall environments. Mtb FecB and FecB2 are predicted periplasmic binding proteins implicated in host iron acquisition; however, their precise roles are not well understood. This study sought to differentiate the roles FecB and FecB2 play in Mtb iron acquisition. The crystallographic structures of Mtb FecB and FecB2 were determined to 2.0 Å and 2.2 Å resolution, respectively, and show distinct ligand binding pockets. In vitro ligand binding experiments for FecB and FecB2 were performed with heme and bacterial siderophores from Mtb and other species, revealing that both FecB and FecB2 bind heme, while only FecB binds the Mtb sideophore ferric-carboxymycobactin (Fe-cMB). Subsequent structure-guided mutagenesis of FecB identified a single glutamate residue-Glu339-that significantly contributes to Fe-cMB binding. A role for FecB in the Mtb siderophore-mediated iron acquisition pathway was corroborated by Mycobacterium smegmatis and Mtb pull-down assays, which revealed interactions between FecB and members of the mycobacterial siderophore export and import machinery. Similarly, pull-down assays with FecB2 confirms its role in heme uptake revealing interactions with a potential inner membrane heme importer. Due to ligand preference and protein partners, our data suggest that Mtb FecB plays a role in siderophore-dependent iron and heme acquisition pathways; in addition, we confirm that Mtb FecB2 is involved in heme uptake.

Indexed as

IronMycobacterium tuberculosisBacterial ProteinsHemeHumansLigandsSiderophoresBacterial ProteinsHemeIronLigandsSiderophores

Identifiers

PMID37747938
PMCPMC10553834
OpenAlexW4387011973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.